President and Chief Business Officer
Kareem joined Velsera in May 2026 bringing 25 years of commercial and corporate development experience in Healthcare and Life Sciences, leading $5B+ in strategic transactions. He previously led strategy, transformation and business development at several precision medicine companies including NeoGenomics and GeneDx. He led commercial teams managing $500M+ in Healthcare and Life Sciences portfolios at IBM and Dell Healthcare businesses. He’s passionate about building commercial capability and driving strategic growth to accelerate the realization of personalized healthcare.